8 research outputs found

    Steatosis is not associated with increased risk of chemotherapy-associated liver injury in metastatic colorectal cancer

    No full text
    © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.TR received support for travel from MSD, Daiichi-Sankyo and Novartis. He provides consulting for BioNTech. He receives institutional grant funding from DebioPharm and Gilead, as well as speaker fees from Novartis. He is also a breast cancer expert for NICE. None had influence on this work. KA has a lecturer honorarium received from Advanz Pharma

    Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    No full text

    Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    No full text

    Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    No full text

    Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    No full text

    Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    No full text
    corecore